SinoPep: difference between revisions
Diff·revision 5 → 6·17:24, 12 Jul 2025
Difference between revision 5 and revision 6 of SinoPep. 5 lines changed; the page grew by 1,033 bytes.
| Revision 5 — 10:38, 3 Jul 2025 GIP_Genoveva (talk) expand §Product range 3,724 bytes ±0 | Revision 6 — 17:24, 12 Jul 2025 Ref_Desk_Ron (talk) add the note that this wiki publishes no score and no league table 4,757 bytes +1,033 | ||
|---|---|---|---|
| 10 | The organisation is one of twenty-eight covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} | 10 | The organisation is one of twenty-eight covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} |
| 11 | 11 | ||
| + | 12 | This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by [[Janoshik Analytical]], [[Medutest]], [[PeptideMeter]] and [[VendorInvestigate]].{{r|tally}} | |
| + | 13 | ||
| 12 | == Corporate identity and history == | 14 | == Corporate identity and history == |
| 13 | Incorporated in Changzhou in 2011, the organisation sits in the middle of the incorporation dates among the entities covered on this wiki and predates the current research-peptide trade by several years.{{r|registry}} | 15 | Incorporated in Changzhou in 2011, the organisation sits in the middle of the incorporation dates among the entities covered on this wiki and predates the current research-peptide trade by several years.{{r|registry}} |
| ⋮ | ⋮ | ||
| 15 | The organisation describes itself as performing its own Fmoc solid-phase synthesis rather than finishing material made elsewhere. That is a self-published characterisation and is recorded here as one, not adopted.{{r|selfpub}} What the submitted set does establish is narrower: technical questions about resin selection and purification steps have been answered directly rather than referred onward, which is consistent with the characterisation without confirming it.{{r|reports}} | 17 | The organisation describes itself as performing its own Fmoc solid-phase synthesis rather than finishing material made elsewhere. That is a self-published characterisation and is recorded here as one, not adopted.{{r|selfpub}} What the submitted set does establish is narrower: technical questions about resin selection and purification steps have been answered directly rather than referred onward, which is consistent with the characterisation without confirming it.{{r|reports}} |
| 16 | 18 | ||
| + | 19 | The documentary base for this article is the registry record, the organisation's own material and purchaser-submitted test reports. No independent coverage has been identified, which is a characteristic this article shares with every other supplier article on this wiki and a limit a reader should carry into all of them.{{r|registry}} | |
| + | 20 | ||
| 17 | == Distribution and dispatch == | 21 | == Distribution and dispatch == |
| 18 | The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report. | 22 | The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report. |
| ⋮ | ⋮ | ||
| 23 | <ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref> | 27 | <ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref> |
| 24 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> | 28 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> |
| + | 29 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | |
| 25 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 30 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 26 | 31 |